Klinične raziskave VER-A-T1D

Za to zdravilo, ki znano znižuje raven sladkorja v krvi, so nedavno ugotovili, da zaščiti in okrepi beta celice ter upočasni uničevanje beta celic pri T1D.

Druga raziskava INNODIE, ki se bo začela kmalu, je raziskava z uporabo zdravila Verapamil. Za to zdravilo, ki znano znižuje raven sladkorja v krvi, so nedavno ugotovili, da zaščiti in okrepi beta celice ter upočasni uničevanje beta celic pri T1D. V raziskavi bo 120 bolnikov, starih med 18 in <45 let, jemalo tablete eno leto.

ZA VEČ INFORMACIJ

Spodaj prenesite datoteko pdf:

Other Innodia Trials:

How to Participate:

Select country:

Germany
Germany
Denmark
Great Britain
Finland
France
Italy
Italy
Nederlands
Norway
Poland
Sweden
Slovenia
Austria
Belgium
Belgium
Belgium
Belgium
  • Germany - HKA

    Germany - HKA

  • Germany - UULM

    Germany - UULM

  • France - IN-SERM

    France - INSERM

  • Italy UNISI

    Italy - UNISI

  • Italy UniSR

    Italy - UniSR

  • Poland SUM Katowice

    Poland - SUM Katowice

  • Sweden - ULUND

    Sweden - ULUND

  • Austria - MUG

    Austria - MUG

  • Belgium

    Belgium - UZA

  • Belgium

    Belgium - UZLeuven

  • Belgium

    Belgium - ULB

  • Belgium

    Belgium - UZB

Is your country not available?
Send us a mail so we can contact you when the trial starts close to you!